Conversations with Innovators: Daniel DeAngelo, MD, on Systemic Mastocytosis
2 Views
administrator
07/09/23
Dr. DeAngelo and colleagues examined the highly potent and KIT-specific, oral inhibitor BLU-285 to treat patients with advanced systemic mastocytosis.
-
Category
Show more
Facebook Comments
No comments found